Resolvin E1-d4

Resolvin E1-d₄ (RvE1-d₄) is intended for use as an internal standard for the quantification of RvE1 by GC- or LC-MS. RvE1 is a trihydroxy eicosapentaenoic acid metabolite that has been identified in mouse inflammatory exudates and in human plasma when subjects are treated with both aspirin and supplemental EPA.^1,2,3 RvE1 promotes inflammatory resolution in numerous disease models, including experimental colitis, asthma, atherosclerosis, type 2 diabetes, and HSV-1-induced stromal keratitis.^{4,5,6,7,8,9,10}

1.Serhan, C.N., Clish, C.B., Brannon, J., et al.Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processingJournal of Experimental Medicine192(8)1197-1204(2000) 2.Serhan, C.N., Hong, S., Gronert, K., et al.Resolvins: A family of bioactive products of ω-3 fatty acid transformation circuits by aspirin treatment that counter proinflammation signalsJ. Exp. Med.196(8)1025-1037(2002) 3.Arita, M., Bianchini, F., Aliberti, J., et al.Sterochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1Journal of Experimental Medicine201(5)713-722(2005) 4.Arita, M., Yoshida, M., Hong, S., et al.Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitisProceedings of the National Academy of Sciences of the United States of America102(21)7671-7676(2005) 5.Aoki, H., Hisada, T., Ishizuka, T., et al.Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthmaBiochemical and Biophysical Research Communications367509-515(2008) 6.Haworth, O., Cernadas, M., and Levy, B.D.NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammationJournal of Immunology186(11)6129-6135(2011) 7.Campbell, E.K., MacManus, C.F., Kominsky, D.J., et al.Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxificationProceedings of the National Academy of Sciences of the United States of America107(32)14298-14303(2010) 8.Hasturk, H., Abdallah, R., Kantarck, A., et al.Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesisArteriosclerosis, Thrombosis, and Vascular Biology35(5)1123-1133(2015) 9.Herrera, N.S., Hasturk, H., Kantarck, A., et al.Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetesInfection and Immunity83(2)792-801(2015) 10.Rajasagi, N.K., Reddy, P.B.J., Suryawanshi, A., et al.Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1J. Immunol.186(3)1735-1746(2011)